FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200438707> ?p ?o ?g. }

• W4200438707 endingPage "106043" @default.
• W4200438707 startingPage "106043" @default.
• W4200438707 abstract "Inflammation associated endothelial dysfunction represents a pivotal contributor to atherosclerosis. Increasingly, evidence has demonstrated that interleukin 1 receptor (IL1-R) / toll-like receptor (TLR) signaling participates in the development of atherosclerosis. Recent large-scale clinical trials have supported the therapeutic potential of anti-inflammatory therapies targeting IL-1β and IL-6 in reducing atherosclerosis. The present study examined the pharmacological effects of IL-1R-associated kinase 1 and 4 inhibitors (IRAK1/4i) in regulating inflammation of the endothelium and atherosclerosis. We demonstrate that dual pharmacological inhibition of IRAK1 and IRAK4 by an IRAK1/4i is more effective against LPS induced endothelial inflammation, compared with IRAK1 inhibitor or IRAK4 inhibitor monotherapy. IRAK1/4i showed little endothelial cell toxicity at concentrations from 1 μM up to 10 μM. Inhibition of IRAK1/4 reduced endothelial activation induced by LPS in vitro as evidenced by attenuated monocyte adhesion to the endothelium. Mechanistically, blockade of IRAK1/4 ameliorated the transcriptional activity of NF-κB. To assess the pharmacological effects of IRAK1/4i on atherosclerosis in vivo, ApoE-/- mice were orally administered IRAK1/4i (20 mg/kg/d) for 8 weeks. We show that IRAK1/4i reduced atherosclerotic lesion size in the aortic sinus and increased hepatic LDLR protein levels as well as lowered LDL-C level, without affecting other lipid parameters or glucose tolerance. Taken together, our findings demonstrate that dual pharmacological inhibition of IRAK1 and IRAK4 attenuates endothelial inflammation, lowers LDL-C levels and reduces atherosclerosis. Our study reinforces the evolving standing of anti-inflammatory approaches in cardiovascular therapeutics." @default.
• W4200438707 created "2021-12-31" @default.
• W4200438707 creator A5012775407 @default.
• W4200438707 creator A5019842995 @default.
• W4200438707 creator A5032835568 @default.
• W4200438707 creator A5047341650 @default.
• W4200438707 creator A5051365587 @default.
• W4200438707 creator A5058784085 @default.
• W4200438707 creator A5075494494 @default.
• W4200438707 creator A5086060866 @default.
• W4200438707 creator A5089776239 @default.
• W4200438707 creator A5091284598 @default.
• W4200438707 date "2022-01-01" @default.
• W4200438707 modified "2023-10-16" @default.
• W4200438707 title "Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE-/- mice" @default.
• W4200438707 cites W1493025774 @default.
• W4200438707 cites W1549853453 @default.
• W4200438707 cites W1552829599 @default.
• W4200438707 cites W1594071095 @default.
• W4200438707 cites W1900762885 @default.
• W4200438707 cites W1967768675 @default.
• W4200438707 cites W2018468502 @default.
• W4200438707 cites W2030914021 @default.
• W4200438707 cites W2033925114 @default.
• W4200438707 cites W2039118309 @default.
• W4200438707 cites W2045881743 @default.
• W4200438707 cites W2047463251 @default.
• W4200438707 cites W2051308361 @default.
• W4200438707 cites W2075860675 @default.
• W4200438707 cites W2081555341 @default.
• W4200438707 cites W2089938437 @default.
• W4200438707 cites W2109491705 @default.
• W4200438707 cites W2110926368 @default.
• W4200438707 cites W2113978145 @default.
• W4200438707 cites W2118224132 @default.
• W4200438707 cites W2120058838 @default.
• W4200438707 cites W2122737708 @default.
• W4200438707 cites W2163558504 @default.
• W4200438707 cites W2165576062 @default.
• W4200438707 cites W2168970487 @default.
• W4200438707 cites W2171545875 @default.
• W4200438707 cites W2253394189 @default.
• W4200438707 cites W2569442829 @default.
• W4200438707 cites W2588744787 @default.
• W4200438707 cites W2606830763 @default.
• W4200438707 cites W2621223949 @default.
• W4200438707 cites W2748400555 @default.
• W4200438707 cites W2765500225 @default.
• W4200438707 cites W2891420275 @default.
• W4200438707 cites W2955354807 @default.
• W4200438707 cites W2986700515 @default.
• W4200438707 cites W3081761942 @default.
• W4200438707 cites W3165793489 @default.
• W4200438707 cites W3198628905 @default.
• W4200438707 cites W4211134725 @default.
• W4200438707 cites W4249880233 @default.
• W4200438707 doi "https://doi.org/10.1016/j.phrs.2021.106043" @default.
• W4200438707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34954030" @default.
• W4200438707 hasPublicationYear "2022" @default.
• W4200438707 type Work @default.
• W4200438707 citedByCount "6" @default.
• W4200438707 countsByYear W42004387072022 @default.
• W4200438707 countsByYear W42004387072023 @default.
• W4200438707 crossrefType "journal-article" @default.
• W4200438707 hasAuthorship W4200438707A5012775407 @default.
• W4200438707 hasAuthorship W4200438707A5019842995 @default.
• W4200438707 hasAuthorship W4200438707A5032835568 @default.
• W4200438707 hasAuthorship W4200438707A5047341650 @default.
• W4200438707 hasAuthorship W4200438707A5051365587 @default.
• W4200438707 hasAuthorship W4200438707A5058784085 @default.
• W4200438707 hasAuthorship W4200438707A5075494494 @default.
• W4200438707 hasAuthorship W4200438707A5086060866 @default.
• W4200438707 hasAuthorship W4200438707A5089776239 @default.
• W4200438707 hasAuthorship W4200438707A5091284598 @default.
• W4200438707 hasConcept C126322002 @default.
• W4200438707 hasConcept C203014093 @default.
• W4200438707 hasConcept C2776246508 @default.
• W4200438707 hasConcept C2776914184 @default.
• W4200438707 hasConcept C2776992346 @default.
• W4200438707 hasConcept C2780972559 @default.
• W4200438707 hasConcept C502942594 @default.
• W4200438707 hasConcept C71924100 @default.
• W4200438707 hasConcept C98274493 @default.
• W4200438707 hasConceptScore W4200438707C126322002 @default.
• W4200438707 hasConceptScore W4200438707C203014093 @default.
• W4200438707 hasConceptScore W4200438707C2776246508 @default.
• W4200438707 hasConceptScore W4200438707C2776914184 @default.
• W4200438707 hasConceptScore W4200438707C2776992346 @default.
• W4200438707 hasConceptScore W4200438707C2780972559 @default.
• W4200438707 hasConceptScore W4200438707C502942594 @default.
• W4200438707 hasConceptScore W4200438707C71924100 @default.
• W4200438707 hasConceptScore W4200438707C98274493 @default.
• W4200438707 hasLocation W42004387071 @default.
• W4200438707 hasLocation W42004387072 @default.
• W4200438707 hasOpenAccess W4200438707 @default.
• W4200438707 hasPrimaryLocation W42004387071 @default.
• W4200438707 hasRelatedWork W1607531870 @default.
• W4200438707 hasRelatedWork W2022809694 @default.

• next